Livzon Pharmaceutical Group Inc.’s Net Profit Dropped 3.2% in First Three Quarters of 2022

Livzon Pharmaceutical Group Inc. (丽珠医药集团股份有限公司) (000513.SZ) reported a net profit of 1.6 billion yuan in the first three quarters of 2022, down 3.2% year-on-year.

Meanwhile, the company posted 9.5 billion yuan in revenue, up 1.3% year-on-year.

At the end of the reporting period, it had 23.6 billion yuan in total assets and 9.1 billion yuan in total liabilities, with a liability-to-asset ratio of 38.4%.